---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-029868"
form_type: "8-K"
ticker: "ZVSA"
cik: "0001859007"
company_name: "ZyVersa Therapeutics, Inc."
filed_at: "2024-08-01T23:59:59+00:00"
generated_at: "2026-05-31T14:01:41.213449+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ZyVersa raises ~$830k via warrant inducement at $3.46; issues 200% new warrants

## Summary
- Holder exercises existing Series A/B warrants at reduced price $3.46 (from $12.50), gross proceeds ~$830k.
- New Series A-1 warrants for 392k shares (5-yr term) and Series B-1 for 86.6k shares (18-mo term), all at $3.46.
- New warrant shares subject to stockholder approval; meeting to be held within 90 days of closing.
- Engaged A.G.P./Alliance Global Partners as financial advisor for $50k cash fee.
- Company to file resale registration statement for new warrant shares by September 2, 2024.

## SEC filing metadata
- accession: 0001493152-24-029868
- form_type: 8-K
- ticker: ZVSA
- cik: 0001859007
- company_name: ZyVersa Therapeutics, Inc.
- filed_at: 2024-08-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859007/000149315224029868/0001493152-24-029868-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859007/000149315224029868/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-029868
- JSON: https://secwatch.observer/filing/0001493152-24-029868.json
- Plain text: https://secwatch.observer/filing/0001493152-24-029868.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.